US Capitol Capsule: Lack of R&D investment could drive US innovation overseas, White House panel says
This article was originally published in Scrip
Executive Summary
As the political theater continued last week in Washington over how to avert the fiscal cliff – the convergence in January of the end of the Bush-era tax breaks and the start of the $1 trillion across-the-board sequestration cuts to federal agencies and programs – a presidential advisory panel warned that if bold investments are not made in US research, the growing threat to the nation's leadership role in science, technology and innovation will only heighten, harming the American economy.
You may also be interested in...
Moderna's Valera Takes mRNA Approach To Combat Zika
With new funding in hand, Moderna and its infectious disease venture Valera are going full-speed ahead with a Zika vaccine, taking an mRNA approach, which they said could be a more rapid strategy to try to stop the disease.
Allergan's Price Reform Pledge: Will Others Follow?
Allergan CEO Brent Saunders vows not to engage in price gouging and says his firm will limit cost increases to single-digit percentages, occurring only once per year. But it's unclear whether Saunders will stand as a lone wolf in the industry or if others will make similar pledges.
Clinton's Drug Price Plan: Threat Or Flash In The Political Pan?
Hillary Clinton's plan to rein in high prices of older medicines, which includes creating a federal panel that has authority to impose fines, may grab headlines, but some analysts think it's unlikely to get very far in a divided Washington.